CH375356A - Verfahren zur Herstellung von neuen substituierten Succinimiden - Google Patents

Verfahren zur Herstellung von neuen substituierten Succinimiden

Info

Publication number
CH375356A
CH375356A CH7124959A CH7124959A CH375356A CH 375356 A CH375356 A CH 375356A CH 7124959 A CH7124959 A CH 7124959A CH 7124959 A CH7124959 A CH 7124959A CH 375356 A CH375356 A CH 375356A
Authority
CH
Switzerland
Prior art keywords
preparation
new substituted
substituted succinimides
succinimides
new
Prior art date
Application number
CH7124959A
Other languages
English (en)
Inventor
Ernst Dr Jucker
Rudolf Dr Sueess
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to CH7124959A priority Critical patent/CH375356A/de
Priority to GB5371/60A priority patent/GB936477A/en
Priority to US14556A priority patent/US3056796A/en
Priority to BE588948A priority patent/BE588948A/fr
Priority to DES67724A priority patent/DE1211646B/de
Priority to DK113860AA priority patent/DK94619C/da
Priority to ES0256774A priority patent/ES256774A1/es
Priority to AT227660A priority patent/AT215992B/de
Priority to LU38418A priority patent/LU38418A1/xx
Priority to FR837274A priority patent/FR507M/fr
Priority to DE19631470238 priority patent/DE1470238A1/de
Publication of CH375356A publication Critical patent/CH375356A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
CH7124959A 1959-03-25 1959-03-25 Verfahren zur Herstellung von neuen substituierten Succinimiden CH375356A (de)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CH7124959A CH375356A (de) 1959-03-25 1959-03-25 Verfahren zur Herstellung von neuen substituierten Succinimiden
GB5371/60A GB936477A (en) 1959-03-25 1960-02-15 Improvements in or relating to substituted succinimides
US14556A US3056796A (en) 1959-03-25 1960-03-14 2.8-diazaspiro(4.5)decane-1.3 diones
BE588948A BE588948A (fr) 1959-03-25 1960-03-23 Nouveaux succinimides substitués et leur préparation.
DES67724A DE1211646B (de) 1959-03-25 1960-03-24 Verfahren zur Herstellung von Spirosuccinimiden und deren Salzen
DK113860AA DK94619C (da) 1959-03-25 1960-03-24 Fremgangsmåde til fremstilling af spiro-(piperidyl-4)-succinimidforbindelser.
ES0256774A ES256774A1 (es) 1959-03-25 1960-03-24 Procedimiento para la obtenciën de nuevas succinimidas sustituidas
AT227660A AT215992B (de) 1959-03-25 1960-03-25 Verfahren zur Herstellung von neuen, substituierten Succinimiden
LU38418A LU38418A1 (de) 1959-03-25 1960-06-23
FR837274A FR507M (de) 1959-03-25 1960-08-30
DE19631470238 DE1470238A1 (de) 1959-03-25 1963-04-09 Verfahren zur Herstellung substituierter Succinimide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH7124959A CH375356A (de) 1959-03-25 1959-03-25 Verfahren zur Herstellung von neuen substituierten Succinimiden

Publications (1)

Publication Number Publication Date
CH375356A true CH375356A (de) 1964-02-29

Family

ID=4530864

Family Applications (1)

Application Number Title Priority Date Filing Date
CH7124959A CH375356A (de) 1959-03-25 1959-03-25 Verfahren zur Herstellung von neuen substituierten Succinimiden

Country Status (4)

Country Link
US (1) US3056796A (de)
AT (1) AT215992B (de)
CH (1) CH375356A (de)
DK (1) DK94619C (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2268647A4 (de) * 2008-03-21 2011-05-18 Gen Hospital Corp Verbindungen und zusammensetzungen für den nachweis und die behandlung von morbus alzheimer und verwandten erkrankungen
US10058625B2 (en) 2004-02-24 2018-08-28 The General Hospital Corporation Catalytic radiofluorination
US10098974B2 (en) 2004-02-24 2018-10-16 The General Hospital Corporation Catalytic radiofluorination

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518275A (en) * 1964-03-24 1970-06-30 Sandoz Ag 8-carbobenzoxy-1,3,8-triazaspiro(4,5)decane-2,4-dione
BE897058A (fr) * 1982-06-25 1983-12-16 Sandoz Sa Utilisation d'un derive du spiro-succinimide dans le traitement de la demence du type alzheimer
US20080247964A1 (en) * 2006-05-08 2008-10-09 Yuelian Xu Substituted azaspiro derivatives
US20180250270A1 (en) 2015-09-11 2018-09-06 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB592016A (en) * 1945-02-07 1947-09-04 Wellcome Found Improvements relating to the synthesis of derivatives of piperidine
US2978454A (en) * 1955-09-12 1961-04-04 Sterling Drug Inc Lower alkyl-4-phenyl-1-[(diloweralkoxy phenyl)-aliphatic] piperidine-4-carboxylates

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10058625B2 (en) 2004-02-24 2018-08-28 The General Hospital Corporation Catalytic radiofluorination
US10098974B2 (en) 2004-02-24 2018-10-16 The General Hospital Corporation Catalytic radiofluorination
US10695449B2 (en) 2004-02-24 2020-06-30 The General Hospital Corporation Catalytic radiofluorination
EP2268647A4 (de) * 2008-03-21 2011-05-18 Gen Hospital Corp Verbindungen und zusammensetzungen für den nachweis und die behandlung von morbus alzheimer und verwandten erkrankungen
JP2011515417A (ja) * 2008-03-21 2011-05-19 ザ ジェネラル ホスピタル コーポレイション アルツハイマー病及び関連疾患の検出及び治療のための化合物及び組成物
US8450466B2 (en) 2008-03-21 2013-05-28 The General Hosptial Corporation Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders
AU2009225407B2 (en) * 2008-03-21 2013-09-05 The General Hospital Corporation Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders
US9005578B2 (en) 2008-03-21 2015-04-14 Fluoropharma, Inc. Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders
US10857247B2 (en) 2008-03-21 2020-12-08 The General Hospital Corporation Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders

Also Published As

Publication number Publication date
US3056796A (en) 1962-10-02
AT215992B (de) 1961-07-10
DK94619C (da) 1962-10-29

Similar Documents

Publication Publication Date Title
CH370197A (de) Verfahren zur Herstellung von Actinospectacin
CH387047A (de) Verfahren zur Herstellung von Ketosidopurinen
CH400144A (de) Verfahren zur Herstellung von 16-Methylen-17a-hydroxy-progesteron-17-acylaten
CH419127A (de) Verfahren zur Herstellung von substituierten 3-Pyrrolidinolen
CH375356A (de) Verfahren zur Herstellung von neuen substituierten Succinimiden
CH404962A (de) Verfahren zur Herstellung von Eupolyoxymethylenen
CH396026A (de) Verfahren zur Herstellung von Halogenalkylaminen
CH399742A (de) Verfahren zur Herstellung von Eupolyoxymethylenen
CH387606A (de) Verfahren zur Herstellung von Tetrahydroxydibor
AT217464B (de) Verfahren zur Herstellung von neuen substituierten Pyrrolidonen
CH387029A (de) Verfahren zur Herstellung von 9a-Fluor-11B-oxy-16a-methylprogesteron
AT214939B (de) Verfahren zur Herstellung von neuen 7-Theophyllinderivaten
CH372297A (de) Verfahren zur Herstellung von 4-2-tert.-Aminomethyl-3-keto-steroiden
CH380730A (de) Verfahren zur Herstellung von 4-Methoxy-2-methyl-6-sulfanilamidopyrimidin
CH385861A (de) Verfahren zur Herstellung von neuen Sulfanilamido-pyrazolen
CH400110A (de) Verfahren zur Herstellung von 2-Trifluormethylbenzhydrol
CH378344A (de) Verfahren zur Herstellung von 2-Amino-anthrachinonen
AT232501B (de) Verfahren zur Herstellung von neuen substituierten Bisphenyläthylenen
AT231990B (de) Verfahren zur Herstellung von neuen 5-Phenoxymethyl-2-oxazolidonen
AT221088B (de) Verfahren zur Herstellung von neuen Imidazol-chinonen
AT229314B (de) Verfahren zur Herstellung von neuen 2-Pyridyl-indenen
CH388305A (de) Verfahren zur Herstellung von neuen Benzolsulfonylharnstoffen
AT221092B (de) Verfahren zur Herstellung von substituierten 2-Oxo-benzochinolizinen
CH374670A (de) Verfahren zur Herstellung von neuen Isoindolinderivaten
CH374067A (de) Verfahren zur Herstellung von neuen Isoindolinderivaten